{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:18:51Z","timestamp":1783941531728,"version":"3.55.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12325-016-0343-4","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T16:57:42Z","timestamp":1465577862000},"page":"910-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Management of Pemphigus Vulgaris"],"prefix":"10.1007","volume":"33","author":[{"given":"Mimansa","family":"Cholera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Chainani-Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"issue":"2","key":"343_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1468-3083.2010.03753.x","volume":"25","author":"G Chaidemenos","year":"2011","unstructured":"Chaidemenos G, Apalla Z, Koussidou T, Papagarifallou I, Ioannides D. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. J Eur Acad Dermatol Venereol. 2011;25(2):206\u201310. doi: 10.1111\/j.1468-3083.2010.03753.x [Epub 2010 Jun 21].","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"343_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1875-595X.2003.tb00654.x","volume":"53","author":"SZ Burgan","year":"2003","unstructured":"Burgan SZ, Sawair FA, Napier SS. Case report: oral pemphigus vulgaris with multiple oral polyps in a young patient. Int Dent J. 2003;53(1):37\u201340.","journal-title":"Int Dent J"},{"issue":"1","key":"343_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2334\/josnusd.48.43","volume":"48","author":"A Iamaroon","year":"2006","unstructured":"Iamaroon A, Boonyawong P, Klanrit P, Prasongtunskul S, Thongprasom K. Characterization of oral pemphigus vulgaris in Thai patients. J Oral Sci. 2006;48(1):43\u20136.","journal-title":"J Oral Sci"},{"issue":"4","key":"343_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cden.2013.06.002","volume":"57","author":"FA Santoro","year":"2013","unstructured":"Santoro FA, Stoopler ET, Werth VP. Pemphigus. Dent Clin North Am. 2013;57(4):597\u2013610. doi: 10.1016\/j.cden.2013.06.002 (Epub 2013 Aug 12. Review).","journal-title":"Dent Clin North Am"},{"issue":"4","key":"343_CR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-263X.2005.00640.x","volume":"15","author":"A Ariyawardana","year":"2005","unstructured":"Ariyawardana A, Tilakaratne WM, Dissanayake M, et al. Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report. Int J Paediatr Dent. 2005;15(4):287\u201393.","journal-title":"Int J Paediatr Dent"},{"issue":"5","key":"343_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jop.12022","volume":"42","author":"P Deyhimi","year":"2013","unstructured":"Deyhimi P, Tavakoli P. Study of apoptosis in oral pemphigus vulgaris using immunohistochemical marker Bax and TUNEL technique. J Oral Pathol Med. 2013;42(5):409\u201314. doi: 10.1111\/jop.12022 [Epub 2012 Nov 27].","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"343_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1902\/jop.2005.76.1.154","volume":"76","author":"H Endo","year":"2005","unstructured":"Endo H, Rees TD, Matsue M, Kuyama K, Nakadai M, Yamamoto H. Early detection and successful management of oral pemphigus vulgaris: a case report. J Periodontol. 2005;76(1):154\u201360.","journal-title":"J Periodontol"},{"issue":"1","key":"343_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","volume":"30","author":"M Meurer","year":"2012","unstructured":"Meurer M. Immunosuppressive therapy for autoimmune bullous diseases. Clin Dermatol. 2012;30(1):78\u201383. doi: 10.1016\/j.clindermatol.2011.03.013 .","journal-title":"Clin Dermatol"},{"issue":"2","key":"343_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","volume":"132","author":"JC Bystryn","year":"1996","unstructured":"Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132(2):203\u201312.","journal-title":"Arch Dermatol"},{"issue":"6","key":"343_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","volume":"58","author":"DF Murrell","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58(6):1043\u20136. doi: 10.1016\/j.jaad.2008.01.012 [Epub 2008 Mar 14].","journal-title":"J Am Acad Dermatol"},{"key":"343_CR11","unstructured":"Becker KL, editor. Principles and practice of endocrinology and metabolism, 3rd ed. 2001. Philadelphia: Lippincott Williams & Wilkins"},{"issue":"9","key":"343_CR12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archderm.1977.01640090084013","volume":"113","author":"WF Lever","year":"1977","unstructured":"Lever WF, Schaumburg-Lever G. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol. 1977;113(9):1236\u201341.","journal-title":"Arch Dermatol"},{"issue":"1","key":"343_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1984.01650370050009","volume":"120","author":"WF Lever","year":"1984","unstructured":"Lever WF, Schaumburg-Lever G. Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol. 1984;120(1):44\u20137.","journal-title":"Arch Dermatol"},{"issue":"2","key":"343_CR14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0030-4220(82)90212-2","volume":"54","author":"F Lozada","year":"1982","unstructured":"Lozada F, Silverman S, Cram D. Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone. Oral Surg Oral Med Oral Pathol. 1982;54(2):161\u20135.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"3","key":"343_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000248536","volume":"177","author":"M David","year":"1988","unstructured":"David M, Zaidenbaum M, Sandbank M. Juvenile pemphigus vulgaris: a 4- to 19-year follow-up of 4 patients. Dermatologica. 1988;177(3):165\u20139.","journal-title":"Dermatologica"},{"issue":"1","key":"343_CR16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0030-4220(92)90215-C","volume":"74","author":"PJ Lamey","year":"1992","unstructured":"Lamey PJ, Rees TD, Binnie WH, Wright JM, Rankin KV, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol. 1992;74(1):54\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"343_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-4362.1990.tb04767.x","volume":"29","author":"S Kaur","year":"1990","unstructured":"Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol. 1990;29(5):371\u20134.","journal-title":"Int J Dermatol"},{"issue":"3","key":"343_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000057886","volume":"204","author":"AJ Kanwar","year":"2002","unstructured":"Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus. Dermatology. 2002;204(3):228\u201331.","journal-title":"Dermatology"},{"issue":"5","key":"343_CR19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","volume":"142","author":"LF Mentink","year":"2006","unstructured":"Mentink LF, Mackenzie MW, T\u00f3th GG, et al. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol. 2006;142(5):570\u20136 (Erratum in: Arch Dermatol. 2006 Aug;142(8):1014. Dosage error in article text).","journal-title":"Arch Dermatol"},{"issue":"6","key":"343_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00007691-199512000-00023","volume":"17","author":"JT Ransom","year":"1995","unstructured":"Ransom JT. Mechanism of action of mycophenolate mofetil. Ther Drug Monit. 1995;17(6):681\u20134.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"343_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","volume":"149","author":"AM Powell","year":"2003","unstructured":"Powell AM, Albert S, Al Fares S, et al. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol. 2003;149(1):138\u201345.","journal-title":"Br J Dermatol"},{"key":"343_CR22","unstructured":"Scheinfeld NS. Intravenous immunoglobulin. Drugs Dis Proced. Medscape Reference; 2011. Web 14 Mar 2016."},{"issue":"4","key":"343_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clindermatol.2013.01.005","volume":"31","author":"E Ruocco","year":"2013","unstructured":"Ruocco E, Wolf R, Ruocco V, Brunetti G, Romano F, Lo Schiavo A. Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol. 2013;31(4):382\u201390. doi: 10.1016\/j.clindermatol.2013.01.005 .","journal-title":"Clin Dermatol"},{"issue":"7","key":"343_CR24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/imt.12.67","volume":"4","author":"D Tsuruta","year":"2012","unstructured":"Tsuruta D, Ishii N, Hashimoto T. Diagnosis and treatment of pemphigus. Immunotherapy. 2012;4(7):735\u201345.","journal-title":"Immunotherapy"},{"issue":"7","key":"343_CR25","first-page":"ELT24","volume":"88","author":"L Virgolini","year":"2003","unstructured":"Virgolini L, Marzocchi V. Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory pemphigus vulgaris: report of a case. Haematologica. 2003;88(7):ELT24.","journal-title":"Haematologica"},{"issue":"1","key":"343_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.135.1.57","volume":"135","author":"ME Fleischli","year":"1999","unstructured":"Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol. 1999;135(1):57\u201361.","journal-title":"Arch Dermatol"},{"issue":"6","key":"343_CR27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0190-9622(08)80651-2","volume":"28","author":"ML Chaffins","year":"1993","unstructured":"Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol. 1993;28(6):998\u20131000.","journal-title":"J Am Acad Dermatol"},{"key":"343_CR28","doi-asserted-by":"publisher","first-page":"CD006263","DOI":"10.1002\/14651858.CD006263.pub2","volume":"1","author":"LK Martin","year":"2009","unstructured":"Martin LK, Werth V, Villanueva E, Segall J, Murrell DF. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev. 2009;1:CD006263. doi: 10.1002\/14651858.CD006263.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"343_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","volume":"42","author":"A Herbst","year":"2000","unstructured":"Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol. 2000;42(3):422\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"343_CR30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2334\/josnusd.50.359","volume":"50","author":"S Dagistan","year":"2008","unstructured":"Dagistan S, Goregen M, Miloglu O, Cakur B. Oral pemphigus vulgaris: a case report with review of the literature. J Oral Sci. 2008;50(3):359\u201362.","journal-title":"J Oral Sci"},{"issue":"9","key":"343_CR31","first-page":"667","volume":"71","author":"N Ben Lagha","year":"2005","unstructured":"Ben Lagha N, Poulesquen V, Roujeau JC, Alantar A, Maman L. Pemphigus vulgaris: a case-based update. J Can Dent Assoc. 2005;71(9):667\u201372.","journal-title":"J Can Dent Assoc"},{"issue":"4 Suppl","key":"343_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.47102\/annals-acadmedsg.V33N4p63S","volume":"33","author":"NA Robinson","year":"2004","unstructured":"Robinson NA, Yeo JF, Lee YS, Aw DC. Oral pemphigus vulgaris: a case report and literature update. Ann Acad Med Singapore. 2004;33(4 Suppl):63\u20138.","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"343_CR33","first-page":"282","volume":"10","author":"F Camacho-Alonso","year":"2005","unstructured":"Camacho-Alonso F, L\u00f3pez-Jornet P, Bermejo-Fenoll A. Pemphigus vulgaris. A presentation of 14 cases and review of the literature. Med Oral Patol Oral Cir Bucal. 2005;10(4):282\u20138.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"3","key":"343_CR34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","volume":"153","author":"MJ Arin","year":"2005","unstructured":"Arin MJ, Engert A, Krieg T, Hunzelmann N. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol. 2005;153(3):620\u20135.","journal-title":"Br J Dermatol"},{"issue":"7","key":"343_CR35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","volume":"150","author":"K Heelan","year":"2014","unstructured":"Heelan K, Al-Mohammedi F, Smith MJ, et al. Durable remission of pemphigus with a fixed-dose rituximab protocol. JAMA Dermatol. 2014;150(7):703\u20138.","journal-title":"JAMA Dermatol"},{"issue":"10","key":"343_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13023-015-0263-4","volume":"22","author":"A Baican","year":"2015","unstructured":"Baican A, Chiorean R, Leucuta DC, et al. Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study. Orphanet J Rare Dis. 2015;22(10):48. doi: 10.1186\/s13023-015-0263-4 .","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"343_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","volume":"67","author":"G Cianchini","year":"2012","unstructured":"Cianchini G, Lupi F, Masini C, Corona R, Puddu P, De Pit\u00e0 O. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. J Am Acad Dermatol. 2012;67(4):617\u201322. doi: 10.1016\/j.jaad.2011.11.007 [Epub 2012 Jan 13].","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"343_CR38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","volume":"44","author":"C Chams-Davatchi","year":"2005","unstructured":"Chams-Davatchi C, Valikhani M, Daneshpazhooh M, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol. 2005;44(6):470\u20136.","journal-title":"Int J Dermatol"},{"issue":"12","key":"343_CR39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1346-8138.2006.00193.x","volume":"33","author":"KD Yazgano\u011flu","year":"2006","unstructured":"Yazgano\u011flu KD, Baykal C, K\u00fc\u00e7\u00fcko\u011flu R. Childhood pemphigus vulgaris: five cases in 16 years. J Dermatol. 2006;33(12):846\u20139.","journal-title":"J Dermatol"},{"issue":"1","key":"343_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archderm.1971.04000190016003","volume":"104","author":"JG Ryan","year":"1971","unstructured":"Ryan JG. Pemphigus. A 20-year survey of experience with 70 cases. Arch Dermatol. 1971;104(1):14\u201320.","journal-title":"Arch Dermatol"},{"issue":"3","key":"343_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archderm.1973.01620180083027","volume":"107","author":"BW Berger","year":"1973","unstructured":"Berger BW, Maier HS, Kantor I, Wexler DE. Pemphigus vulgaris in a 3\u00bd-year old boy. Arch Dermatol. 1973;107(3):433\u20134. doi: 10.1001\/archderm.1973.01620180083027 .","journal-title":"Arch Dermatol"},{"issue":"7","key":"343_CR42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","volume":"112","author":"FR Rosenberg","year":"1976","unstructured":"Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol. 1976;112(7):962\u201370.","journal-title":"Arch Dermatol"},{"issue":"3 Pt 1","key":"343_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","volume":"16","author":"W Aberer","year":"1987","unstructured":"Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol. 1987;16(3 Pt 1):527\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"343_CR44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-4362.1988.tb02409.x","volume":"27","author":"M Seidenbaum","year":"1988","unstructured":"Seidenbaum M, David M, Sandbank M. The course and prognosis of pemphigus. A review of 115 patients. Int J Dermatol. 1988;27(8):580\u20134.","journal-title":"Int J Dermatol"},{"issue":"5","key":"343_CR45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0030-4220(90)90245-N","volume":"69","author":"G Laskaris","year":"1990","unstructured":"Laskaris G, Stoufi E. Oral pemphigus vulgaris in a 6-year-old girl. Oral Surg Oral Med Oral Pathol. 1990;69(5):609\u201313 (Review).","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"12","key":"343_CR46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","volume":"132","author":"VP Werth","year":"1996","unstructured":"Werth VP. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. Arch Dermatol. 1996;132(12):1435\u20139.","journal-title":"Arch Dermatol"},{"issue":"4","key":"343_CR47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1079-2104(97)90030-5","volume":"84","author":"JC Robinson","year":"1997","unstructured":"Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(4):349\u201355.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"343_CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1034\/j.1600-0714.2000.290401.x","volume":"29","author":"MD Mignogna","year":"2000","unstructured":"Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. J Oral Pathol Med. 2000;29(4):145\u201352.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"343_CR49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2133.1999.02612.x","volume":"140","author":"C Scully","year":"1999","unstructured":"Scully C, Paes De Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol. 1999;140(1):84\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"343_CR50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1468-3083.2002.00504.x","volume":"16","author":"S Ljubojevi\u0107","year":"2002","unstructured":"Ljubojevi\u0107 S, Lipozenci\u0107 J, Brenner S, Budimci\u0107 D. Pemphigus vulgaris: a review of treatment over a 19-year period. J Eur Acad Dermatol Venereol. 2002;16(6):599\u2013603.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"343_CR51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1468-3083.2002.00461.x","volume":"16","author":"F Femiano","year":"2002","unstructured":"Femiano F, Gombos F, Scully C. Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols. J Eur Acad Dermatol Venereol. 2002;16(4):353\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"343_CR52","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-3083.2007.02286.x","volume":"21","author":"GCh Chaidemenos","year":"2007","unstructured":"Chaidemenos GCh, Mourellou O, Koussidou T, Tsatsou F. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study. J Eur Acad Dermatol Venereol. 2007;21(10):1386\u201391.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"343_CR53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","volume":"57","author":"C Chams-Davatchi","year":"2007","unstructured":"Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622\u20138 Epub 2007 Jun 21.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"343_CR54","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/bjd.12474","volume":"169","author":"KD Tran","year":"2013","unstructured":"Tran KD, Wolverton JE, Soter NA. Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients. Br J Dermatol. 2013;169(4):916\u201321. doi: 10.1111\/bjd.12474 .","journal-title":"Br J Dermatol"},{"issue":"10","key":"343_CR55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1468-3083.2010.03610.x","volume":"24","author":"MD Mignogna","year":"2010","unstructured":"Mignogna MD, Fortuna G, Leuci S, Adamo D, Dell\u2019Aversana Orabona G, Ruoppo E. Adjuvant triamcinolone acetonide injections in oro-pharyngeal pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2010;24(10):1157\u201365. doi: 10.1111\/j.1468-3083.2010.03610.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"343_CR56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1995.tb02497.x","volume":"133","author":"O Mourellou","year":"1995","unstructured":"Mourellou O, Chaidemenos GC, Koussidou T, Kapetis E. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol. 1995;133(1):83\u20137.","journal-title":"Br J Dermatol"},{"issue":"10","key":"343_CR57","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","volume":"27","author":"C Chams-Davatchi","year":"2013","unstructured":"Chams-Davatchi C, Mortazavizadeh A, Daneshpazhooh M, et al. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2013;27(10):1285\u201392. doi: 10.1111\/j.1468-3083.2012.04717.x [Epub 2012 Oct 15].","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"343_CR58","first-page":"54","volume":"135","author":"AH Enk","year":"1999","unstructured":"Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol. 1999;135(1):54\u20136.","journal-title":"Arch Dermatol"},{"issue":"6 Pt 1","key":"343_CR59","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","volume":"40","author":"M Grundmann-Kollmann","year":"1999","unstructured":"Grundmann-Kollmann M, Korting HC, Behrens S, et al. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol. 1999;40(6 Pt 1):957\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"343_CR60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","volume":"139","author":"D Mimouni","year":"2003","unstructured":"Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139(6):739\u201342.","journal-title":"Arch Dermatol"},{"issue":"11","key":"343_CR61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","volume":"142","author":"S Beissert","year":"2006","unstructured":"Beissert S, Werfel T, Frieling U, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142(11):1447\u201354.","journal-title":"Arch Dermatol"},{"issue":"3","key":"343_CR62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2010.02.052","volume":"64","author":"LC Strowd","year":"2011","unstructured":"Strowd LC, Taylor SL, Jorizzo JL, Namazi MR. Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission. J Am Acad Dermatol. 2011;64(3):490\u20134. doi: 10.1016\/j.jaad.2010.02.052 [Epub 2010 Jul 14].","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"343_CR63","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2010.91","volume":"130","author":"S Beissert","year":"2010","unstructured":"Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. J Invest Dermatol. 2010;130(8):2041\u20138. doi: 10.1038\/jid.2010.91 [Epub 2010 Apr 22].","journal-title":"J Invest Dermatol"},{"issue":"6","key":"343_CR64","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-4632.2009.04291.x","volume":"49","author":"MR Bongiorno","year":"2010","unstructured":"Bongiorno MR, Pistone G, Doukaki S, Aric\u00f2 M. Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus. Int J Dermatol. 2010;49(6):693\u20139. doi: 10.1111\/j.1365-4632.2009.04291.x .","journal-title":"Int J Dermatol"},{"issue":"7","key":"343_CR65","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","volume":"26","author":"D Ioannides","year":"2012","unstructured":"Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study. J Eur Acad Dermatol Venereol. 2012;26(7):855\u201360. doi: 10.1111\/j.1468-3083.2011.04170.x [Epub 2011 Jul 14].","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"343_CR66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","volume":"47","author":"JC Bystryn","year":"2002","unstructured":"Bystryn JC, Jiao D, Natow S. Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol. 2002;47(3):358\u201363.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"343_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","volume":"60","author":"M Amagai","year":"2009","unstructured":"Amagai M, Ikeda S, Pemphigus Study Group, et al. A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol. 2009;60(4):595\u2013603. doi: 10.1016\/j.jaad.2008.09.052 .","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"343_CR68","first-page":"101","volume":"28","author":"V Rakocevi\u0107-Stojanovi\u0107","year":"2009","unstructured":"Rakocevi\u0107-Stojanovi\u0107 V, Rakocevi\u0107 I, Peri\u0107 S, Lavrni\u0107 D. Intravenous immunoglobulin therapy in two patients with myasthenia gravis and pemphigus vulgaris. Acta Myol. 2009;28(3):101\u20132.","journal-title":"Acta Myol"},{"issue":"1","key":"343_CR69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.1969.01610250076018","volume":"100","author":"WF Lever","year":"1969","unstructured":"Lever WF, Goldberg HS. Treatment of pemphigus vulgaris with methotrexate. Arch Dermatol. 1969;100(1):70\u20138.","journal-title":"Arch Dermatol"},{"issue":"2","key":"343_CR70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1970.tb15707.x","volume":"83","author":"S Jablonska","year":"1970","unstructured":"Jablonska S, Chorzelski T, Blaszczyk M. Immunosuppressants in the treatment of pemphigus. Br J Dermatol. 1970;83(2):315\u201323 (Review).","journal-title":"Br J Dermatol"},{"issue":"3","key":"343_CR71","first-page":"171","volume":"58","author":"T Piamphongsant","year":"1975","unstructured":"Piamphongsant T, Sivayathorn A. Pemphigus: combined treatment with methotrexate and prednisone. J Med Assoc Thai. 1975;58(3):171\u20136.","journal-title":"J Med Assoc Thai"},{"issue":"9","key":"343_CR72","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archderm.1977.01640090084013","volume":"113","author":"WF Lever","year":"1977","unstructured":"Lever WF, Schaumburg-Lever G. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol. 1977;113(9):1236\u201341.","journal-title":"Arch Dermatol"},{"issue":"4","key":"343_CR73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archderm.1972.01620130023006","volume":"106","author":"WF Lever","year":"1972","unstructured":"Lever WF. Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970. Arch Dermatol. 1972;106(4):491\u20137.","journal-title":"Arch Dermatol"},{"issue":"5","key":"343_CR74","first-page":"413","volume":"68","author":"N Mashkilleyson","year":"1988","unstructured":"Mashkilleyson N, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin. Acta Derm Venereol. 1988;68(5):413\u201321.","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"343_CR75","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archderm.135.10.1275","volume":"135","author":"TJ Smith","year":"1999","unstructured":"Smith TJ, Bystryn JC. Methotrexate as an adjuvant treatment for pemphigus vulgaris. Arch Dermatol. 1999;135(10):1275\u20136.","journal-title":"Arch Dermatol"},{"issue":"1","key":"343_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1684\/ejd.2011.1611","volume":"22","author":"S Baum","year":"2012","unstructured":"Baum S, Greenberger S, Samuelov L, et al. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris. Eur J Dermatol. 2012;22(1):83\u20137. doi: 10.1684\/ejd.2011.1611 .","journal-title":"Eur J Dermatol"},{"issue":"5","key":"343_CR77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2002.126273","volume":"47","author":"TG Salopek","year":"2002","unstructured":"Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol. 2002;47(5):785\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"343_CR78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2230.2003.01283.x","volume":"28","author":"HL Cooper","year":"2003","unstructured":"Cooper HL, Healy E, Theaker JM, Friedmann PS. Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (rituximab). Clin Exp Dermatol. 2003;28(4):366\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"343_CR79","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2003.08.021","volume":"50","author":"A Espa\u00f1a","year":"2004","unstructured":"Espa\u00f1a A, Fern\u00e1ndez-Galar M, Lloret P, S\u00e1nchez-Ibarrola A, Panizo C. Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations. J Am Acad Dermatol. 2004;50(6):974\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"343_CR80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","volume":"51","author":"LH Morrison","year":"2004","unstructured":"Morrison LH. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J Am Acad Dermatol. 2004;51(5):817\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"343_CR81","first-page":"185","volume":"85","author":"J Wenzel","year":"2005","unstructured":"Wenzel J, Bauer R, Bieber T, T\u00fcting T. Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants. Acta Derm Venereol. 2005;85(2):185\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"343_CR82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archderm.140.1.91","volume":"140","author":"A Dupuy","year":"2004","unstructured":"Dupuy A, Viguier M, B\u00e9dane C, et al. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol. 2004;140(1):91\u20136.","journal-title":"Arch Dermatol"},{"issue":"5","key":"343_CR83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1470.2005.00118.x","volume":"22","author":"HH Kong","year":"2005","unstructured":"Kong HH, Prose NS, Ware RE, Hall RP 3rd. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol. 2005;22(5):461\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"343_CR84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.2005.06740.x","volume":"153","author":"E Schmidt","year":"2005","unstructured":"Schmidt E, Herzog S, Br\u00f6cker EB, Zillikens D, Goebeler M. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol. 2005;153(2):449\u201351.","journal-title":"Br J Dermatol"},{"issue":"2","key":"343_CR85","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","volume":"156","author":"E Schmidt","year":"2007","unstructured":"Schmidt E, Seitz CS, Benoit S, Br\u00f6cker EB, Goebeler M. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol. 2007;156(2):352\u20136.","journal-title":"Br J Dermatol"},{"issue":"17","key":"343_CR86","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","volume":"355","author":"AR Ahmed","year":"2006","unstructured":"Ahmed AR, Spigelman Z, Cavacini LA, Posner MR. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med. 2006;355(17):1772\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"343_CR87","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","volume":"156","author":"MS Goh","year":"2007","unstructured":"Goh MS, McCormack C, Dinh HV, Welsh B, Foley P, Prince HM. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients. Br J Dermatol. 2007;156(5):990\u20136 [Epub 2007 Mar 13].","journal-title":"Br J Dermatol"},{"issue":"4","key":"343_CR88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000099591","volume":"214","author":"AV Marzano","year":"2007","unstructured":"Marzano AV, Fanoni D, Venegoni L, Berti E, Caputo R. Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab). Dermatology. 2007;214(4):310\u20138.","journal-title":"Dermatology"},{"issue":"3","key":"343_CR89","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/09546630701286110","volume":"18","author":"A Antonucci","year":"2007","unstructured":"Antonucci A, Negosanti M, Tabanelli M, Varotti C. Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases. J Dermatol Treat. 2007;18(3):178\u201383.","journal-title":"J Dermatol Treat"},{"issue":"8","key":"343_CR90","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","volume":"143","author":"G Cianchini","year":"2007","unstructured":"Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch Dermatol. 2007;143(8):1033\u20138 (Review).","journal-title":"Arch Dermatol"},{"issue":"6","key":"343_CR91","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","volume":"357","author":"P Joly","year":"2007","unstructured":"Joly P, Mouquet H, Roujeau JC, et al. A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med. 2007;357(6):545\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"343_CR92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","volume":"158","author":"I Shimanovich","year":"2008","unstructured":"Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol. 2008;158(2):382\u20138 [Epub 2007 Dec 6].","journal-title":"Br J Dermatol"},{"issue":"12","key":"343_CR93","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1038\/jid.2008.172","volume":"128","author":"R Eming","year":"2008","unstructured":"Eming R, Nagel A, Wolff-Franke S, Podstawa E, Debus D, Hertl M. Rituximab exerts a dual effect in pemphigus vulgaris. J Invest Dermatol. 2008;128(12):2850\u20138. doi: 10.1038\/jid.2008.172 [Epub 2008 Jun 19].","journal-title":"J Invest Dermatol"},{"issue":"3","key":"343_CR94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-4632.2008.03423.x","volume":"47","author":"A Faurschou","year":"2008","unstructured":"Faurschou A, Gniadecki R. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris. Int J Dermatol. 2008;47(3):292\u20134. doi: 10.1111\/j.1365-4632.2008.03423.x .","journal-title":"Int J Dermatol"},{"issue":"3","key":"343_CR95","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000187431","volume":"218","author":"M Pf\u00fctze","year":"2009","unstructured":"Pf\u00fctze M, Eming R, Kneisel A, Kuhlmann U, Hoyer J, Hertl M. Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab. Dermatology. 2009;218(3):237\u201345. doi: 10.1159\/000187431 Epub 2008 Dec 16.","journal-title":"Dermatology"},{"issue":"1","key":"343_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000287254","volume":"221","author":"I Fuertes","year":"2010","unstructured":"Fuertes I, Guilabert A, Mascar\u00f3 JM Jr, Iranzo P. Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. Dermatology. 2010;221(1):13\u20136. doi: 10.1159\/000287254 (Epub 2010 Apr 9. Review).","journal-title":"Dermatology"},{"issue":"1","key":"343_CR97","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2133.2011.10585.x","volume":"166","author":"M Kasperkiewicz","year":"2012","unstructured":"Kasperkiewicz M, Shimanovich I, Meier M, et al. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil: a pilot study of 23 patients. Br J Dermatol. 2012;166(1):154\u201360. doi: 10.1111\/j.1365-2133.2011.10585.x [Epub 2011 Oct 17].","journal-title":"Br J Dermatol"},{"issue":"8","key":"343_CR98","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1600-0714.2011.01017.x","volume":"40","author":"E Craythorne","year":"2011","unstructured":"Craythorne E, du Viver A, Mufti GJ, Warnakulasuriya S. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. J Oral Pathol Med. 2011;40(8):616\u201320. doi: 10.1111\/j.1600-0714.2011.01017.x [Epub 2011 Mar 9].","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"343_CR99","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jaad.2010.07.032","volume":"65","author":"M Kasperkiewicz","year":"2011","unstructured":"Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol. 2011;65(3):552\u20138. doi: 10.1016\/j.jaad.2010.07.032 .","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"343_CR100","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10411.x","volume":"165","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kim YH, Kim MR, Kim SC. Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients. Br J Dermatol. 2011;165(3):646\u201351. doi: 10.1111\/j.1365-2133.2011.10411.x .","journal-title":"Br J Dermatol"},{"issue":"4","key":"343_CR101","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jaad.2011.12.019","volume":"67","author":"Z Reguiai","year":"2012","unstructured":"Reguiai Z, Tabary T, Maizi\u00e8res M, Bernard P. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up. J Am Acad Dermatol. 2012;67(4):623\u20139. doi: 10.1016\/j.jaad.2011.12.019 [Epub 2012 Jan 20].","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"343_CR102","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","volume":"166","author":"B Horv\u00e1th","year":"2012","unstructured":"Horv\u00e1th B, Huizinga J, Pas HH, Mulder AB, Jonkman MF. Low-dose rituximab is effective in pemphigus. Br J Dermatol. 2012;166(2):405\u201312. doi: 10.1111\/j.1365-2133.2011.10663.x [Epub 2012 Jan 9].","journal-title":"Br J Dermatol"},{"issue":"3","key":"343_CR103","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2133.2011.10658.x","volume":"166","author":"RJ Feldman","year":"2012","unstructured":"Feldman RJ, Christen WG, Ahmed AR. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy. Br J Dermatol. 2012;166(3):511\u20137. doi: 10.1111\/j.1365-2133.2011.10658.x [Epub 2012 Jan 19].","journal-title":"Br J Dermatol"},{"issue":"3","key":"343_CR104","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","volume":"68","author":"YA Leshem","year":"2013","unstructured":"Leshem YA, Hodak E, David M, Anhalt GJ, Mimouni D. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. J Am Acad Dermatol. 2013;68(3):404\u201311. doi: 10.1016\/j.jaad.2012.08.010 [Epub 2012 Oct 6].","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"343_CR105","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","volume":"148","author":"L Lunardon","year":"2012","unstructured":"Lunardon L, Tsai KJ, Propert KJ, et al. Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients. Arch Dermatol. 2012;148(9):1031\u20136. doi: 10.1001\/archdermatol.2012.1522 .","journal-title":"Arch Dermatol"},{"issue":"10","key":"343_CR106","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1610-0387.2012.07931.x","volume":"10","author":"M Kasperkiewicz","year":"2012","unstructured":"Kasperkiewicz M, Eming R, Behzad M, Hunzelmann N, et al. Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases. J Dtsch Dermatol Ges. 2012;10(10):727\u201332. doi: 10.1111\/j.1610-0387.2012.07931.x [Epub 2012 May 11].","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"343_CR107","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-4632.2012.5847.x","volume":"52","author":"K Balighi","year":"2013","unstructured":"Balighi K, Daneshpazhooh M, Khezri S, Mahdavi-nia M, Hajiseyed-javadi M, Chams-Davatchi C. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial. Int J Dermatol. 2013;52(7):862\u20137. doi: 10.1111\/j.1365-4632.2012.5847.x (Erratum in: Int J Dermatol. 2013 Oct;52(10):1292. Kamran, Balighi [corrected to Balighi, Kamran]; Maryam, Daneshpazhooh [corrected to Daneshpazhooh, Maryam]; Somayeh, Khezri [corrected to Khezri, Somayeh]; Mostafa, Mahdavi-nia [corrected to Mahdavi-nia, Mostafa]; Mahsa, Hajiseyed-javadi [corrected to Hajiseyed-javadi, Mahsa]; Cheyda, Chams-Davatchi [corrected to Chams-Davatchi, Cheyda]).","journal-title":"Int J Dermatol"},{"issue":"1","key":"343_CR108","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1111\/j.1468-3083.2011.04391.x","volume":"27","author":"AJ Kanwar","year":"2013","unstructured":"Kanwar AJ, Tsuruta D, Vinay K, et al. Efficacy and safety of rituximab treatment in Indian pemphigus patients. J Eur Acad Dermatol Venereol. 2013;27(1):e17\u201323. doi: 10.1111\/j.1468-3083.2011.04391.x [Epub 2011 Dec 17].","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"343_CR109","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jdv.12175","volume":"28","author":"M Kolesnik","year":"2014","unstructured":"Kolesnik M, Becker E, Reinhold D, et al. Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication. J Eur Acad Dermatol Venereol. 2014;28(6):771\u201380. doi: 10.1111\/jdv.12175 [Epub 2013 May 8].","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"343_CR110","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/bjd.12972","volume":"170","author":"AJ Kanwar","year":"2014","unstructured":"Kanwar AJ, Vinay K, Sawatkar GU, et al. Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study. Br J Dermatol. 2014;170(6):1341\u20139. doi: 10.1111\/bjd.12972 .","journal-title":"Br J Dermatol"},{"issue":"3","key":"343_CR111","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/imj.12674","volume":"45","author":"S Ojaimi","year":"2015","unstructured":"Ojaimi S, O\u2019Connor K, Lin MW, Schifter M, Fulcher DA. Treatment outcomes in cohort of patients with mucosal-predominant pemphigus vulgaris. Intern Med J. 2015;45(3):284\u201392. doi: 10.1111\/imj.12674 .","journal-title":"Intern Med J"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0343-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T14:12:38Z","timestamp":1718633558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0343-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}